Internal Tandem Duplications of Flt3 Gene (Flt3/ITD) Predicts a Poor Post-Remission Outcome in Adult Patients with Acute Non-Promyelocytic Leukemia

References

• Lowenberg, B., Downing, J.R. and Burnett, AK. (1999) "Acute myeloid leukemia", New England Journal of Medicine, 341(14), 1051 — 1062.
   PubMed Web of Science ®Google Scholar
• Harousseau, J.L. (1998) "Acute myeloid leukemia in the elderly", Blood Review, 12(3), 145–153.
   PubMed Web of Science ®Google Scholar
• Wheatley, K., Burnett, AK., Goldstone, A.H., Gray, R.G., Hann, TM., Harrison, C.J., et al. (1999) "A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom medical Research Council's Adult and Childhood Leukaemia Working Parties", British Journal of Haematology, 107(1), 69–79.
   Google Scholar
• Ferrara, F. and Mirto, S. (1996) "Serum LDH as a predictor of clinicla outcome in acute myelogenous leukaemia of the eldelry", British Journal of Haematology, 92(3), 627–631.
   PubMed Web of Science ®Google Scholar
• Slovak, ML., Kopecky, K.J., Cassileth, PA., Harrington, D.H., Theil, KS., Mohamed, A., et al. for the South Oncology Group and the Eastern Cooperative Oncology Group. (2000) "Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative oncology group study", Blood, 96(13), 4075 — 4083.
   PubMed Web of Science ®Google Scholar
• Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., et al. (1999) "Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia", Blood, 93(9), 3074— 3080.
   PubMed Web of Science ®Google Scholar
• Rombouts, W.J., Blokland, I., Lowenberg, B. and Ploemacher, R.E. (2000) "Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the F1t3 gene", Leukemia, 14(4), 675–683.
   PubMed Web of Science ®Google Scholar
• Fröhling, S., Schlenk, R.F., Breitruck, J., Benner, A., Kreitmeier, S., Tobis, K., et al. (2002) "Prognostic significance of FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics. A study of the AML Study Group ULM", Blood, 100(13), 4372–4380.
   Google Scholar
• Kainz, B., Heintel, D., Marculescu, R., Scwarzinger, I., Sperr, W., Le, T., et al. (2002) "Variable prognostic value of flt3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16)", Hematological Journal, 3(6), 283— 289.
   Google Scholar
• Kiyoi, H. and Naoe, T. (2002) "FLT3 in human hematologic malignancies", Leukemia and Lymphoma, 43(8), 1541 — 1547.
   PubMed Web of Science ®Google Scholar
• Levis, M., Tse, K.F., Smith, D., Garrett, E. and Small, D. (2001) "A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplica-tion mutations", Blood, 98(3), 885–887.
   PubMed Web of Science ®Google Scholar
• Kelly, L.M., Liu, Q., Kutok, J.L., Williams, I.R., Boulton, C.L. and Gilliland, D. (2002) "FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myelopro-liferative disease in a murine bone marrow transplant model", Blood, 99(1), 310–318.
   PubMed Web of Science ®Google Scholar
• Estey, E., Plunkett, W., Gandhi, V., Rios, M., Kantarjian, H. and Keating, M. (1993) "Fludarabine and arabinosylcytosine therapy for refractory and relapsed acute myelogenous leukemia", Leukemia and Lymphoma, 9(4–5), 343–350.
   Web of Science ®Google Scholar
• Mitelman, F. (ed) ISCN (1995) An International System for Human Cytogenetic Nomenclature. Basel: S. Karger.
   Google Scholar
• Grimwade, D., Walker, H., Harrison, G., Oliver, F., Chatters, S., Harrison, C.J., et al. on behalf of the Medical Research Council Adult Leukemia Working Party. (2001) "The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom research Council AML11 Trial", Blood, 98(5), 1312— 1320.
   PubMed Web of Science ®Google Scholar
• Schoch, C., Haase, D., Haferlach, T., Gudat, H., Buchner, T., Freund, M., et al. (1996) "Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22):an additional deletion in 9q is an adverse prognostic factor", Leukemia, 10(8), 1288 — 1295.
   PubMed Web of Science ®Google Scholar
• Kaplan, E.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observation", Journal of the American Statistical Association, 53, 457 — 481.
   Web of Science ®Google Scholar
• Peto, R., Pike, MC., Armitage, P., Breslow, N.E., Cox, DR., Howard, S.V., et al. (1977) "Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples", British Journal of Cancer, 35(1), 1 — 39.
   PubMed Web of Science ®Google Scholar
• Kottaridis, P.D., Gale, RE., Frew, ME., Harrison, G., Langabeer, SE., Belton, A.A., et al. (2001) "The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk groups and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials", Blood, 98(6), 1752— 1759.
   PubMed Web of Science ®Google Scholar
• Stirewall, D.L., Kopechy, K.J., Meshinchi, S., Appelbaum, F.R., Slovak, M.L., Willman, C.L., et al. (2001) "FLT3, RAS, TP53 mutations in elderly patients with acute myeloid leukemia", Blood, 97(11), 3589–3595.
   PubMed Web of Science ®Google Scholar
• Schnittger, S., Schoch, C., Dugas, M., Kern, W., Staib, P., Wuchter, C., et al. (2002) "Analysis of FLT3 lenght mutation in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AML G study and usefulness as marker for the detection of minimal residual disease", Blood, 100(1), 59–66.
   PubMed Web of Science ®Google Scholar
• Boissel, N., Cayuela, J.M., Preudhomme, C., Thomas, X., Grardel, N., Fund, X., et al. (2002) "Prognostic significance of FLT3 internal tandem repeat in patients wiyh de novo acute myeloid leukemia with reinforced courses of chemotherapy", Leukemia, 16(9), 1699 — 1704.
   PubMed Web of Science ®Google Scholar
• Martinelli, G., Piccaluga, P. and Lo Coco, F. (2003) "FLT3 inhibition as tailored therapy for acute myeloid leukemia", Haematologica, 88(1), 4–7.
   PubMed Web of Science ®Google Scholar